G Hessler, KH Baringhaus - Molecules, 2018 - mdpi.com
… of artificialintelligence in the field of property or activity prediction, de novo design and … systems has been largely increased over recent years, now also comprising de novo design or …
W Duch, K Swaminathan… - … pharmaceutical design, 2007 - ingentaconnect.com
… , machinelearning and artificialintelligence approaches play an increasingly important role in rational drugdesign, … role of machinelearning and artificialintelligence approaches in …
… design. Nevertheless, extravagant claims have been made for the ability of ArtificialIntelligence (AI) to accelerate the design … on whether novel artificialintelligence methods contribute …
… the representative applications in small molecule drugdesign; and briefly introduced how DL … how they were used in DL applications for small molecule drugdesign and development. …
AA Arabi - Future Drug Discovery, 2021 - Taylor & Francis
… drugs is rapidly growing due to advances in machinelearning (ML) and artificialintelligence … This review covers myriad faces of AI and ML in drugdesign. There is a plethora of AI …
… drugs. These AI and ML methods are applied in every step of the computer-aided drugdesign, and … drugdesign, along with its challenge and opportunity for the pharmaceutical industry. …
… use of artificialintelligence (AI) systems in drugdesign. Neural … run SciPy or NumPy packages included in drugdesign tools. … recent developments in the field of drugdesign based on AI. …
… drugdesign approaches such as structure-and ligand-based, augmented and multi-objective de novo drugdesign… , ADMET, pharmacokinetics and drug-target residence time, precision …
… Machinelearning (ML) is becoming capable of transforming biomolecular interaction description and calculation, promising an impact on molecular and drugdesign, chemical biology, …